Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-21
2007-08-21
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S222200, C514S228800, C514S250000, C514S262100, C514S263220, C514S252030, C514S255050, C514S256000, C514S314000, C514S315000, C514S330000, C514S336000, C514S351000, C514S354000, C514S357000, C514S365000, C546S169000, C546S180000, C546S193000, C546S194000, C546S198000, C546S199000, C546S201000, C546S207000, C546S208000, C546S209000, C546S210000, C546S211000, C546S212000, C546S213000, C546S224000, C546S226000, C546S229000, C546S231000, C546S236000, C546S237000, C544S238000, C544S262000, C544S277000, C544S
Reexamination Certificate
active
10114685
ABSTRACT:
Compounds represented by Formula (I):or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
REFERENCES:
patent: 5306723 (1994-04-01), Chenard et al.
patent: 5436255 (1995-07-01), Butler et al.
patent: 5648368 (1997-07-01), Egertson et al.
patent: 6197769 (2001-03-01), Alisi et al.
patent: 6303637 (2001-10-01), Bao et al.
patent: 6706740 (2004-03-01), Ricks et al.
patent: 3702755 (1988-08-01), None
patent: 441506 (1991-08-01), None
patent: 532456 (1993-03-01), None
patent: 787493 (1997-08-01), None
patent: 846683 (1998-06-01), None
patent: WO91/17156 (1991-11-01), None
patent: WO91/19709 (1991-12-01), None
patent: 9203415 (1992-03-01), None
patent: WO92/18502 (1992-10-01), None
patent: WO93/02052 (1993-02-01), None
patent: WO94/20062 (1994-02-01), None
patent: WO94/14776 (1994-07-01), None
patent: WO94/21615 (1994-09-01), None
patent: WO96/02250 (1996-02-01), None
patent: WO96/10035 (1996-04-01), None
patent: WO96/34856 (1996-11-01), None
patent: WO96/37226 (1996-11-01), None
patent: WO97/28139 (1997-08-01), None
patent: WO97/28141 (1997-08-01), None
patent: WO97/45119 (1997-12-01), None
patent: WO98/04913 (1998-02-01), None
patent: WO98/05336 (1998-02-01), None
patent: WO98/31669 (1998-07-01), None
patent: WO98/31677 (1998-07-01), None
patent: WO98/46589 (1998-10-01), None
patent: WO 00/00197 (2000-01-01), None
patent: WO 00/08015 (2000-02-01), None
patent: WO 00/11002 (2000-03-01), None
patent: WO 00/25786 (2000-05-01), None
patent: WO 00 71518 (2000-11-01), None
patent: 100207 (2001-01-01), None
Richter et al,PubMed Abstract 12498913, also cited as Eur.J.Pharmacol. 458/1-2,107-10(2003).
Kuraishi et al,PubMed Abstract 113338373,also cited as Nippon Yakurigaku Zasshi,117/4,248-54(2001).
Wright et al,PubMed Abstract 10522697, also cited as Bioorg. Med. Chem. Lett.,9/19,2815-8(1999).
Chabrier et al, PubMed Abstract 10442086, also cited as Cell Mol. Life Sci.,55/8-9,1029-35(1999).
Laurie et al,PubMed Abstract 7528680, also cited as Eur. J. Pharmacol. 268/3,335-45(1994).
Alisi et al. Chemical Abstracts, vol. 129:316219, 1998.
Ricks et al., Chemical Abstracts, vol. 134:131431, 2001.
T. Ishii, et al., J.Biol. Chem., 268:2836-2843(1993).
M.B. Max, et al., Clin. Neuropharmacology, 18:360-368(1995).
D.J. Knox, et al., Anaesth. Intens. Care, 23:620-622(1995).
P.K. Eide, et al., Pain, 61:221-228(1995).
J.D. Kristensen, et al., Pain, 51:249-253(1992).
K. Taniguchi, et al., Brit. J. Pharmacology, 122:809-812(1997).
R. Jain, et al., Tetrahedron, 54:3235-3242(1998).
W. Danysz, et al., Pharmacological Rev., 50:597-664(1998).
R.D. Clark, et al., J. Med. Chem., 26:855-861(1983).
A. Dickenson, TIPS, 11:307-309(1990).
A. Wenzel, et al., Neurochemistry, 7:45-48(1995).
J.N.C. Kew, et al., Brit. J. Pharmacology, 123:463-472(1998).
Electronic Database Printout, CAPLUS 1999:617466,218th ACS Nat. Mtg., N. Orleans, Aug. 22-26, 1999.
Z.-L. Zhou, et al., J. Med. Chem., 42:2993-3000(1999).
S. Boyce, et al., Neuropharmacology, 38:611-623(1999).
D.J. Laurie, et al., Mol. Brain Res., 51:23-32(1997).
Electronic Database Printout CAPLUS STN No. 98:191287 (1983).
Electronic Database Printout CAPLUS STN No. 135:298146 (2001).
Butcher John W.
Claiborne Christopher F.
Claremon David A.
Liverton Nigel J.
McCauley John A.
Merck & Co. , Inc.
O'Sullivan Peter
Rose David L.
Yang Mollie M.
LandOfFree
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828740